APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
DNA mutations induced by dysregulated APOBEC3 expression are associated with tumour-progression and therapeutic resistance, but also with the generation of neoepitopes. Here, the authors show that APOBEC3 function can be exploited in a vaccine setting to generate heteroclitic neoepitopes, enhancing...
Guardado en:
Autores principales: | Christopher B. Driscoll, Matthew R. Schuelke, Timothy Kottke, Jill M. Thompson, Phonphimon Wongthida, Jason M. Tonne, Amanda L. Huff, Amber Miller, Kevin G. Shim, Amy Molan, Cynthia Wetmore, Peter Selby, Adel Samson, Kevin Harrington, Hardev Pandha, Alan Melcher, Jose S. Pulido, Reuben Harris, Laura Evgin, Richard G. Vile |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b522666697f4ba891fb72be5cba002f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy
por: Timothy Kottke, et al.
Publicado: (2021) -
Oncolytic virus-derived type I interferon restricts CAR T cell therapy
por: Laura Evgin, et al.
Publicado: (2020) -
Pan-cancer analysis of neoepitopes
por: Gabriel N. Teku, et al.
Publicado: (2018) -
Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
por: Huahui Yu, et al.
Publicado: (2021) -
Leveraging Immunopeptidomics To Study and Combat Infectious Disease
por: Owen K. Leddy, et al.
Publicado: (2021)